Management of Fulminant Hepatitis B: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases

Basit Öğe Kaydı
dc.authoridAydın, Mehtap/0000-0003-4044-9366
dc.authoridONCUL, Mustafa Oral/0000-0002-1681-1866
dc.authoridYILDIZ, ORHAN/0000-0001-6019-0430
dc.authoridErtem, Gunay/0000-0001-8760-0030
dc.authoridYILDIZ, ORHAN/0000-0001-6019-0430
dc.authorwosidAydın, Mehtap/HLX-0937-2023
dc.authorwosidONCUL, Mustafa Oral/AAE-3429-2020
dc.authorwosidYILDIZ, ORHAN/B-2193-2018
dc.authorwosidErtem, Gunay/GRJ-7397-2022
dc.authorwosidYILDIZ, ORHAN/HGC-3442-2022
dc.contributor.authorAydin, Mehtap
dc.contributor.authorAygen, Bilgehan
dc.contributor.authorMistik, Resit
dc.contributor.authorOncul, Oral
dc.contributor.authorTuna, Nazan
dc.contributor.authorTuncer-Ertem, Gunay
dc.contributor.authorYildiz, Orhan
dc.date.accessioned2024-06-12T10:50:34Z
dc.date.available2024-06-12T10:50:34Z
dc.date.issued2013
dc.departmentTrakya Üniversitesien_US
dc.description.abstractStudy Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases set up a task force to develop a consensus report focused on fulminant hepatitis B, the only infection for which an effective antiviral approach is available. Both antiviral and non-antiviral therapies were reviewed in the report. Some practical recommendations from relevant guidelines of three international associations (i.e., European Association for the Study of the Liver, American Association for the Study of Liver Disease, and Asian Pacific Association for the Study of the Liver) were adopted, and listed with the level of evidence and the grade of recommendation at the end of the report.en_US
dc.identifier.doi10.5152/kd.2013.13
dc.identifier.endpage11en_US
dc.identifier.issn1301-143X
dc.identifier.issn1309-1484
dc.identifier.issue1en_US
dc.identifier.startpage2en_US
dc.identifier.urihttps://doi.org/10.5152/kd.2013.13
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18052
dc.identifier.volume26en_US
dc.identifier.wosWOS:000420932800002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofKlimik Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Liver Failureen_US
dc.subjectFulminant Hepatitis Ben_US
dc.subjectAntiviral Agentsen_US
dc.titleManagement of Fulminant Hepatitis B: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseasesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu